A novel redox-responsive ursolic acid polymeric prodrug delivery system for osteosarcoma therapy

References

• Baishya R, Nayak DK, Kumar D, et al. (2016). Ursolic acid loaded PLGA nanoparticles: in vitro and in vivo evaluation to explore tumor targeting ability on B16F10 melanoma cell lines. Pharm Res 33:2691–703.
   PubMed Web of Science ®Google Scholar
• Bao Y, Guo Y, Zhuang X, et al. (2014). D-α-Tocopherol polyethylene glycol succinate-based redox-sensitive paclitaxel prodrug for overcoming multidrug resistance in cancer cells. Mol Pharm 11:3196–209.
   PubMed Web of Science ®Google Scholar
• Chang N, Zhao Y, Ge N, Qian L. (2020). A pH/ROS cascade-responsive and self-accelerating drug release nanosystem for the targeted treatment of multi-drug-resistant colon cancer. Drug Deliv 27:1073–86.
   PubMed Web of Science ®Google Scholar
• Chen D, Ge S, Zuo L, et al. (2020). Adjudin-loaded redox-sensitive paclitaxel-prodrug micelles for overcoming multidrug resistance with efficient targeted Colon cancer therapy. Drug Deliv 27:1094–105.
   PubMed Web of Science ®Google Scholar
• Chen Y, Jiao Y, Ge Y, et al. (2017). The study of tacrolimus-loaded polyion complex micelles for oral delivery. J Biomed Nanotechnol 13:1147–57.
   PubMed Web of Science ®Google Scholar
• Duan R, Li C, Wang F, Yangi JC. (2017). Polymer-lipid hybrid nanoparticles-based paclitaxel and etoposide combinations for the synergistic anticancer efficacy in osteosarcoma . Colloids Surf B Biointerfaces 159:880–7.
   PubMed Web of Science ®Google Scholar
• Goos JACM, Cho A, Carter LM, et al. (2020). Delivery of polymeric nanostars for molecular imaging and endoradiotherapy through the enhanced permeability and retention (EPR) effect. Theranostics 10:567–84.
   PubMed Web of Science ®Google Scholar
• Guo X, Cheng Y, Zhao X, et al. (2018). Advances in redox-responsive drug delivery systems of tumor microenvironment. J Nanobiotechnology 16:74.
   PubMed Web of Science ®Google Scholar
• Ji X, Tang Q, Pang P, et al. (2018). Redox-responsive chemosensitive polyspermine delivers ursolic acid targeting to human breast tumor cells: the depletion of intracellular GSH contents arouses chemosensitizing effects. Colloids Surf B Biointerfaces 170:293–302.
   PubMed Web of Science ®Google Scholar
• Jia L, Li Z, Zhang D, et al. (2013). Redox-responsive catiomer based on PEG-ss-chitosan oligosaccharide-ss-polyethylenimine copolymer for effective gene delivery. Polym Chem 4:156–65.
   Web of Science ®Google Scholar
• Jiang K, Chi T, Li T, et al. (2017). A smart pH-responsive nano-carrier as a drug delivery system for the targeted delivery of ursolic acid: suppresses cancer growth and metastasis by modulating P53/MMP-9/PTEN/CD44 mediated multiple signaling pathways. Nanoscale 9:9428–39.
   PubMed Web of Science ®Google Scholar
• Liu Y, Liu K, Li X, et al. (2018). A novel self-assembled nanoparticle platform based on pectin-eight-arm polyethylene glycol-drug conjugates for co-delivery of anticancer drugs. Mater Sci Eng C Mater Biol Appl 86:28–41.
   PubMed Web of Science ®Google Scholar
• Liu YX, Liu KF, Li CX, et al. (2017). Self-assembled nanoparticles based on a carboxymethylcellulose–ursolic acid conjugate for anticancer combination therapy. RSC Adv 7:36256–68.
   Web of Science ®Google Scholar
• Lv S, Tang Z, Zhang D, et al. (2014). Well-defined polymer-drug conjugate engineered with redox and pH-sensitive release mechanism for efficient delivery of paclitaxel. J Control Release 194:220–7.
   PubMed Web of Science ®Google Scholar
• Mlala S, Oyedeji AO, Gondwe M, Oyedeji OO. (2019). Ursolic acid and its derivatives as bioactive agents. Molecules 24:2751.
   PubMed Web of Science ®Google Scholar
• Mu X, Gan S, Wang Y, et al. (2019). Stimulus-responsive vesicular polymer nano-integrators for drug and gene delivery. Int J Nanomedicine 14:5415–34.
   PubMed Web of Science ®Google Scholar
• Poudel K, Gautam M, Maharjan S, et al. (2020). Dual stimuli-responsive ursolic acid-embedded nanophytoliposome for targeted antitumor therapy. Int J Pharm 582:119330.
   PubMedGoogle Scholar
• Raza A, Hayat U, Rasheed T, et al. (2018). Redox-responsive nano-carriers as tumor-targeted drug delivery systems. Eur J Med Chem 157:705–15.
   PubMed Web of Science ®Google Scholar
• Seidi F, Jenjob R, Crespy D. (2018). Designing smart polymer conjugates for controlled release of payloads. Chem Rev 118:3965–4036.
   PubMed Web of Science ®Google Scholar
• Shao J, Fang Y, Zhao R, et al. (2020). Evolution from small molecule to nano-drug delivery systems: an emerging approach for cancer therapy of ursolic acid. Asian J Pharm Sci 15:685–700.
   PubMed Web of Science ®Google Scholar
• Shen G, Xing R, Zhang N, et al. (2016). Interfacial cohesion and assembly of bioadhesive molecules for design of long-term stable hydrophobic nanodrugs toward effective anticancer therapy. ACS Nano 10:5720–9.
   PubMed Web of Science ®Google Scholar
• Shen Z, Li B, Liu Y, et al. (2018). A self-assembly nanodrug delivery system based on amphiphilic low generations of PAMAM dendrimers-ursolic acid conjugate modified by lactobionic acid for HCC targeting therapy. Nanomedicine 14:227–36.
   PubMed Web of Science ®Google Scholar
• Sun B, Luo C, Yu H, et al. (2018). Disulfide bond-driven oxidation- and reduction-responsive prodrug nanoassemblies for cancer therapy. Nano Lett 18:3643–50.
   PubMed Web of Science ®Google Scholar
• Wang B, Yu XC, Xu SF, Xu M. (2015). Paclitaxel and etoposide co-loaded polymeric nanoparticles for the effective combination therapy against human osteosarcoma. J Nanobiotechnology 13:22.
   PubMed Web of Science ®Google Scholar
• Wu CC, Cheng CH, Lee YH, et al. (2016). Ursolic acid triggers apoptosis in human osteosarcoma cells via caspase activation and the ERK1/2 MAPK pathway. J Agric Food Chem 64:4220–6.
   PubMed Web of Science ®Google Scholar
• Yang J, Lv Q, Wei W, et al. (2018). Bioresponsive albumin-conjugated paclitaxel prodrugs for cancer therapy. Drug Deliv 25:807–14.
   PubMed Web of Science ®Google Scholar
• Yin W, Ke W, Chen W, et al. (2019). Integrated block copolymer prodrug nanoparticles for combination of tumor oxidative stress amplification and ROS-responsive drug release. Biomaterials 195:63–74.
   PubMed Web of Science ®Google Scholar
• Zhang H, Li X, Ding J, et al. (2013). Delivery of ursolic acid (UA) in polymeric nanoparticles effectively promotes the apoptosis of gastric cancer cells through enhanced inhibition of cyclooxygenase 2 (COX-2). Int J Pharm 441:261–8.
   PubMed Web of Science ®Google Scholar
• Zhang M, Cheng H, Gong Z, et al. (2017). Fabrication of chitosan-18β-glycyrrhetinic acid modified titanium implants with nanorod arrays for suppression of osteosarcoma growth and improvement of osteoblasts activity. Adv Funct Mater 27:1703932.
   Web of Science ®Google Scholar
• Zhang N, Liu S, Shi S, et al. (2020a). Solubilization and delivery of ursolic-acid for modulating tumor microenvironment and regulatory T cell activities in cancer immunotherapy. J Control Release 320:168–78.
   PubMed Web of Science ®Google Scholar
• Zhang RX, Li Y, Tian DD, et al. (2016a). Ursolic acid inhibits proliferation and induces apoptosis by inactivating Wnt/β-catenin signaling in human osteosarcoma cells. Int J Oncol 49:1973–82.
   PubMed Web of Science ®Google Scholar
• Zhang W, Dong D, Li P, et al. (2016b). Novel pH-sensitive polysialic acid based polymeric micelles for triggered intracellular release of hydrophobic drug. Carbohydr Polym 139:75–81.
   PubMed Web of Science ®Google Scholar
• Zhang X, Ren X, Tang J, et al. (2020b). Hyaluronic acid reduction-sensitive polymeric micelles achieving co-delivery of tumor-targeting paclitaxel/apatinib effectively reverse cancer multidrug resistance. Drug Deliv 27:825–35.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Cai L, Li D, et al. (2018). Tumor microenvironment-responsive hyaluronate-calcium carbonate hybrid nanoparticle enables effective chemotherapy for primary and advanced osteosarcomas. Nano Res 11:4806–22.
   Web of Science ®Google Scholar
• Zou J, Zhang F, Zhang S, et al. (2014). Poly(ethylene oxide)-block-polyphosphoester-graft-paclitaxel conjugates with acid-labile linkages as a pH-sensitive and functional nanoscopic platform for paclitaxel delivery. Adv Healthc Mater 3:441–8.
   PubMed Web of Science ®Google Scholar